Evommune, Inc. (EVMN)
17.12
-0.40
(-2.28%)
USD |
NYSE |
Dec 31, 16:00
18.07
+0.95
(+5.55%)
After-Hours: 20:00
Evommune EPS Diluted (Quarterly): -0.3957 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BillionToOne, Inc. | 0.0329 |
| PTC Therapeutics, Inc. | 0.195 |
| Spyre Therapeutics, Inc. | -0.184 |
| Denali Therapeutics, Inc. | -0.736 |
| Quince Therapeutics, Inc. | -0.2492 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.48M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 22.48M |
| Enterprise Value | 721.40M |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | -124.8% |
| Earnings Yield | -10.72% |
| Normalized Earnings Yield | -11.94 |